SCHEMBL9701863

SCHEMBL9701863

Br[Mg]C1SC=Cc2ccccc21

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7054630 0.69 HTR2A (0.38) HTR2A
SCHEMBL9701912 0.69 HTR2A (0.38) HTR2A
SCHEMBL8642000 0.68 HTR2A (0.36) HTR2A
SCHEMBL10354675 0.65 HTR2A (0.38) HTR2A
SCHEMBL363573 0.63 HTR2A (0.32) HTR2A
SCHEMBL11238143 0.63 HTR2A (0.36) HTR2A
SCHEMBL5058579 0.61 GAA (0.35)
SCHEMBL18762880 0.59 HTR2A (0.31) HTR2A
SCHEMBL31046607 0.58 HTR2A (0.43) HTR2A
SCHEMBL6233907 0.58 HTR2A (0.43) HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5120764-A Administering penicillamine and allenylamines to inhibit crosslinking of collagen MERRELL DOW PHARMACEUTICALS INC. (US) 1992-06-09 US disclosed
EP-0374440-A2 Inhibitors of lysyl oxidase MERRELL DOW PHARMACEUTICALS INC. (US) 1990-06-27 EP disclosed